Dose-dependent and time-dependent pharmacokinetics in the dog after intravenous administration of dextrorphan. 1991

P A Cleveland, and S Teller, and V Kachevsky, and E Pinili, and R Evans, and M W Modi
Department of Drug Metabolism, Hoffmann-La Roche Inc., Nutley, NJ 07110.

The disposition of dextrorphan after single ascending iv doses and multiple iv dosing regimens was studied in Marshall beagle dogs. A dose-dependent decrease in plasma clearance was observed after the administration of single iv doses of 0.88 mg/kg, 2.64 mg/kg, and 8.8 mg/kg of dextrorphan (i.e. mean plasma clearance values +/- SD were 100 +/- 25 vs. 68 +/- 28 vs. 48 +/- 20 ml/min.kg, respectively; p less than 0.001). Upon multiple dosing, the plasma clearance of dextrorphan increased in a time-dependent fashion for the two highest doses, approaching values observed for the 0.88 mg/kg/day iv dosing regimen. Female dogs exhibited a greater increase in plasma clearance with time. For all dogs, however, dextrorphan plasma clearance approached or exceeded hepatic plasma flow rate, suggesting the possibility of extrahepatic metabolism or elimination. Modest dose- and time-dependent changes in the steady-state volume of distribution of dextrorphan also were observed. The AUC of the conjugated metabolites of dextrorphan decreased in a time-dependent manner for the 8.8 mg/kg/day dosing regimen. The nonlinear kinetics of dextrorphan after iv administration appeared to occur only after potentially toxic dosing regimens of dextrorphan hydrochloride. We postulate mechanisms to explain the dose- and time-dependent kinetics of dextrorphan observed in the beagle dog.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003917 Dextrorphan Dextro form of levorphanol. It acts as a noncompetitive NMDA receptor antagonist, among other effects, and has been proposed as a neuroprotective agent. It is also a metabolite of DEXTROMETHORPHAN. (+-)-17-Methylmorphinan-3-ol
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012737 Sex Factors Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances. Factor, Sex,Factors, Sex,Sex Factor

Related Publications

P A Cleveland, and S Teller, and V Kachevsky, and E Pinili, and R Evans, and M W Modi
December 1987, Journal of veterinary pharmacology and therapeutics,
P A Cleveland, and S Teller, and V Kachevsky, and E Pinili, and R Evans, and M W Modi
December 2011, Veterinary dermatology,
P A Cleveland, and S Teller, and V Kachevsky, and E Pinili, and R Evans, and M W Modi
January 1987, Clinical therapeutics,
P A Cleveland, and S Teller, and V Kachevsky, and E Pinili, and R Evans, and M W Modi
September 1976, Archives internationales de pharmacodynamie et de therapie,
P A Cleveland, and S Teller, and V Kachevsky, and E Pinili, and R Evans, and M W Modi
August 1988, Chemical & pharmaceutical bulletin,
P A Cleveland, and S Teller, and V Kachevsky, and E Pinili, and R Evans, and M W Modi
May 1983, The Journal of antimicrobial chemotherapy,
P A Cleveland, and S Teller, and V Kachevsky, and E Pinili, and R Evans, and M W Modi
March 1994, Research in veterinary science,
P A Cleveland, and S Teller, and V Kachevsky, and E Pinili, and R Evans, and M W Modi
January 1991, European journal of drug metabolism and pharmacokinetics,
P A Cleveland, and S Teller, and V Kachevsky, and E Pinili, and R Evans, and M W Modi
January 1977, Antimicrobial agents and chemotherapy,
P A Cleveland, and S Teller, and V Kachevsky, and E Pinili, and R Evans, and M W Modi
December 1992, Biopharmaceutics & drug disposition,
Copied contents to your clipboard!